NYSE · Common Stock · Pharmaceutical Preparations
American animal health company
104 entities across 48 jurisdictions, 2 in offshore financial centres. Read directly from the company’s own 10-K EX-21 filed 2026-02-12 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| Abaxis Europe GmbH | Germany | |
| Abaxis, Inc. | United States | |
| Adivo GmbH | Germany | |
| Alpharma (Bermuda), LLC | United States | |
| Alpharma Euro Holdings, LLC | United States | |
| Alpharma Holdings (Barbados) SRL | Barbados | offshore centre |
| Alpharma, LLC | United States | |
| Basepaws Inc | United States | |
| Cross Vetpharm Group Limited | Ireland | |
| Embrex LLC | United States | |
| Jurox Pty Ltd | Australia | |
| PAH 7V6 Holding Limited | Hong Kong | |
| PAH CHHK Holding B.V. | Netherlands | |
| PAH India Holdco LLC | United States | |
| PAH India Holding 1 B.V. | Netherlands | |
| PAH Netherlands 2 B.V. | Netherlands | |
| PAH Oceania B.V. | Netherlands | |
| PAH Spain, S.L. | Spain | |
| Pharmaq Analytiq AS | Norway | |
| Pharmaq Analytiq Limited | United Kingdom | |
| Pharmaq Analytiq SpA | Chile | |
| Pharmaq AS | Norway | |
| Pharmaq AS Chile Limitada | Chile | |
| Pharmaq Fishteq AS | Norway | |
| Pharmaq Fishteq SpA | Chile | |
| Pharmaq Ltd | United Kingdom | |
| Pharmaq Veterinar Ecza Deposu ve su Urunleri Ticaret Ltd Ski | Turkey | |
| Pharmaq Vietnam Company Limited | Vietnam | |
| Platinum Performance, Inc. | United States | |
| PT Zoetis Animalhealth Indonesia | Indonesia | |
| Veterinary Pathology Group Ireland Limited | Ireland | |
| Veterinary Pathology Group Limited | United Kingdom | |
| Virtual Recall Limited | United Kingdom | |
| Virtual Recall Pty Ltd | Australia | |
| Zoetis (Thailand) Limited | Thailand | |
| Zoetis Animal Health ApS | Denmark | |
| Zoetis Argentina S.R.L. | Argentina | |
| Zoetis Australia Pty Ltd | Australia | |
| Zoetis Australia Research & Manufacturing Pty Ltd | Australia | |
| Zoetis B.V. | Netherlands | |
| Zoetis Belgium S.A. | Belgium | |
| Zoetis Biopharmaceutical Co., Ltd | China | |
| Zoetis Canada Inc. | Canada | |
| Zoetis Česká republika, s.r.o. | Czech Republic | |
| Zoetis Colombia S.A.S. | Colombia | |
| Zoetis Comércio E Distribuição Ltda. | Brazil | |
| Zoetis de Chile S.A. | Chile | |
| Zoetis Denmark ApS | Denmark | |
| Zoetis Deutschland GmbH | Germany | |
| Zoetis Egypt LLC | Egypt | |
| Zoetis Egypt Pharmaceuticals LLC | Egypt | |
| Zoetis Egypt Trading LLC | Egypt | |
| Zoetis Enterprise Management (Shanghai) Co., Ltd. | China | |
| Zoetis Finland Oy | Finland | |
| Zoetis France | France | |
| Zoetis Hayvan Sagligi Ltd. Sti. | Turkey | |
| Zoetis Hellas S.A. | Greece | |
| Zoetis Holdings LLC | United States | |
| Zoetis Hungary Kft. | Hungary | |
| Zoetis Import Egypt LLC | Egypt | |
| Zoetis India Capability Center Private Limited | India | |
| Zoetis India Limited | India | |
| Zoetis Indústria de Produtos Veterinários Ltda. | Brazil | |
| Zoetis International Group LLC | United States | |
| Zoetis International Holdings B.V. | Netherlands | |
| Zoetis Ireland Holding ULC | Ireland | |
| Zoetis Israël Holding B.V. | Netherlands | |
| Zoetis Italia S.r.l. | Italy | |
| Zoetis Japan Inc. | Japan | |
| Zoetis Korea Ltd. | South Korea | |
| Zoetis LLC | United States | |
| Zoetis Malaysia Sdn. Bhd. | Malaysia | |
| Zoetis Manufacturing & Research Spain, S.L. | Spain | |
| Zoetis Manufacturing Italia S.R.L. | Italy | |
| Zoetis Mexico, S. de R.L. de C.V. | Mexico | |
| Zoetis Netherlands 3 B.V. | Netherlands | |
| Zoetis Netherlands 4 B.V. | Netherlands | |
| Zoetis New Zealand Limited | New Zealand | |
| Zoetis Österreich GmbH | Austria | |
| Zoetis Overseas Services Inc. | United States | |
| Zoetis Panama S. de R.L. | Panama | offshore centre |
| Zoetis Pharmaceutical Research Private Limited | India | |
| Zoetis Philippines Inc. | Philippines | |
| Zoetis Polska sp. z o.o | Poland | |
| Zoetis Portugal, Lda. | Portugal | |
| Zoetis Reference Laboratories China Co., Ltd. | China | |
| Zoetis Reference Labs LLC | United States | |
| Zoetis Romania SRL | Romania | |
| Zoetis S.R.L. | Peru | |
| Zoetis Schweiz GmbH | Switzerland | |
| Zoetis Services LLC | United States | |
| Zoetis Services UK Limited | United Kingdom | |
| Zoetis Singapore Pte. Ltd. | Singapore | |
| Zoetis South Africa (Pty) Ltd. | South Africa | |
| Zoetis Spain, S.L. | Spain | |
| Zoetis Sweden AB | Sweden | |
| Zoetis Taiwan Limited | Taiwan | |
| Zoetis Treasury Center BV | Belgium | |
| Zoetis UK Limited | United Kingdom | |
| Zoetis Ukraine LLC | Ukraine | |
| Zoetis US LLC | United States | |
| Zoetis Vietnam Limited Liability Company | Vietnam | |
| Zoetis Weesp B.V. | Netherlands | |
| Zoetis WLC LLC | United States |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $6.7B | $1.6B | $1.7B | — | 478,569,000 |
| FY2021 | $7.8B | $2.0B | $1.7B | — | 476,717,000 |
| FY2022 | $8.1B | $2.1B | $1.3B | — | 470,385,000 |
| FY2023 | $8.5B | $2.3B | $1.6B | — | 462,269,000 |
| FY2024 | $9.3B | $2.5B | $2.3B | — | 454,848,000 |
| FY2025 | $9.5B | $2.7B | $2.3B | — | 443,835,000 |
17 institutions tracked — 9 added, 6 reduced, 2 opened a new position. Index money added 6,129,565 shares while active managers cut 1,750,698.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| MORGAN STANLEY | Active fund | 8,878,849 | −5,266,886 | $638.0M |
| CITADEL ADVISORS LLC | Hedge fund | 5,210,963 | +4,222,752 | $374.5M |
| BlackRock, Inc. | Index | 39,430,181 | +3,845,869 | $2.8B |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 13,289,622 | +1,940,374 | $951.8M |
| RENAISSANCE TECHNOLOGIES LLC | Hedge fund | 1,403,300 | +1,151,300 | $100.8M |
| BANK OF AMERICA CORP /DE/ | Active fund | 3,924,926 | −906,726 | $282.0M |
| JPMORGAN CHASE & CO | Active fund | 2,630,925 | −776,249 | $192.7M |
| WELLINGTON MANAGEMENT GROUP LLP | Active fund | 9,423,895 | −726,201 | $677.2M |
| AQR CAPITAL MANAGEMENT LLC | Hedge fund | 1,070,929 | +462,979 | $77.0M |
| STATE STREET CORP | Index | 19,667,723 | +343,322 | $1.4B |
| FMR LLC | Active fund | 380,570 | −182,055 | $27.3M |
| PRICE T ROWE ASSOCIATES INC /MD/ | Active fund | 1,139,097 | +121,009 | $81.9M |
| Point72 Asset Management, L.P. | Hedge fund | 95,300 | +89,500 | $6.8M |
| Bridgewater Associates, LP | Hedge fund | 134,203 | +83,464 | $9.6M |
| BAILLIE GIFFORD & CO | Value | 138,646 | −23,585 | $10.0M |
NORGES BANK, SOROS FUND MANAGEMENT LLC hold a position with no prior filing to compare against, so their change is unknown rather than zero — and they are left out of the totals above.
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
What the company actually paid out and bought back, as reported — the record behind any yield figure.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
Zoetis Inc. files under SIC 2834 — all 50 pharmaceutical preparations companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
